Prevalence of IgM and IgG antibody to HHV-6 and HHV-8 and results of plasma PCR to HHV-6 and HHV-7 in a group of CFS patients and healthy donors

Journal of Chronic Fatigue Syndrome

Volumn 9, Issue 1-2, 2001, Pages 31-40

  Levine, Susan ^a   Eastman, Helen ^b   Ablashi, Dharam V ^b  

^a New Jersey Chronic Fatigue Syndrome Association   (United States)

^b Advanced Biotechnologies Inc   (United States)

Author keywords

Human herpes virus 6; IgG and IgM; PCR testing; Plasma from CFS patients

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; VIRUS CULTURE; VIRUS DETECTION;

EID: 0035772110     PISSN: 10573321     EISSN: None     Source Type: Journal    
DOI: 10.1300/J092v09n01_04     Document Type: Article

References (46)

1. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: A working case definition. Ann Intern Med 1988; 108: 387-389.
2. Fukada K, Strauss SE, Hickie I, et al. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-959.
3. Jones JF. Chronic Epstein Barr Virus Syndrome: Bull NY. Acad Med 1988; 64: 538-543.
4. Strauss SF, Tosato GE, Armstrong G, et al. Persisting illness and fatigue in adults with evidence of Epstein Barr Virus infection. Ann Intern Med 1985; 102: 7-16.
5. Gunn W, Komaroff A, Levine S, Connell D, et al. Multilab retrovirus test results for CFS patients from 3 district geographical areas. MMWR 1997: 1 p.
6. DeFreitas E. Hilliand B, Cheney P, Bell D, et al. Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci. April 1991; 88: 2922-2926.
7. Chia JK, Chia LY. Chronic Chlamydia pneumoniae infection: A treatable cause of chronic fatigue syndrome. CID 1999; 24: 452-453.
8. Lerner MA, Zervas M, Dunkin HI, et al. New cardiomyopathy: pilot study of intravenous gancyclovir in a subset of chronic fatigue syndrome. Infect Dis Clin Prac 1997; 6: 110-117.
9. Jacobson K, Daly JS, Thorne M, Mcintosh K. Chronic parvovirus B 19 infection resulting in chronic fatigue syndrome: Case history and review. Clin Infect Dis 1997; 24: 1048-1051.
10. Levine S. Borna disease virus proteins in patients with CFS. Journal of Chronic Fatigue Syndrome 1999, 5(3/4): 199-206.
11. Ablashi DV, Zumpetta C, Lease C, et al. Human herpesvirus-6 (HHV-6) and chronic Fatigue syndrome (CFS). Can Dis Wkly 1991 b; 1751 E: 33-41.
12. Buchwald D, Cheney P, Peterson DC, Henry VS, et al. A chronic illness characterized by fatigue, neurological and immunological disorders and active human herpesvirus 6 infection. Ann Intern Med 1992; 116: 103-113.
13. Knox KK, Brewer JH, Carrigan DR. Active human herpes virus-6 (HHV-6) infection in patients with chronic fatigue syndrome, Prog 3rd CFS Conf 1988 (Cambridge, MA. 1998) Abstract.
14. Patnaik M, et al. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p 41/38) in patients with chronic fatigue syndrome. J Infect Dis 1995; 172: 1364-1367.
15. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596-601.
16. Schivmer EL, Wyatt LS, Yamamishi IC, Rodriguez WJ, Frenkel W. Differentiation between two district classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci USA 1991; 88: 5922-5926.
17. Ablashi DV, Balachandran W, Josephs SF, Hung CL, Krueger GR, Kramarsky B, et al. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 1991; 184: 545-552.
18. Yamanishi K, Okuno T, Shiraki K, Takahashi M, et al. Identification of human herpes virus-6 as a casual agent for exanthem subitm. Lancet 1988; 1: 1065-1067.
19. Harnett GB, Farr TJ, Pietrobini GR, Bruens MR. Frequent shedding of human herpesvirus-6 in saliva. J Med Virol 1990; 30: 128-130.
20. Cone RW, Huang ML, Hackmar RL, Corey L. Coinfection with human herpesvirus-6 variants A and B in lung tissue. J Clin Microbiol 1996; 34: 877-881.
21. Des Jardin JA, Gibbons L, Cho E, et al. Human herpesvirus-6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients al risk for primary cytomegalovirus infection. J Infect Dis 1998; 178: 1783-1786.
22. Lusso P, Gallo RL. Human herpesvirus-6 in AIDS. Immunol Today 1995; 16: 67-71.
23. Challmer PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, et al. Plaque-associated expression of human herpesvirus-6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 7440-7444.
24. Soldan SS, Berti R, Salem W, et al. Assimilation of human herpes virus-6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Association of Med 1997; 3: 1394-1397.
25. Ablashi DV, Eastman HB, Owen CB, et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue patients. J Clin Virol 2000, 16: 179-191.
26. Lange G, et al. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci 1999; 171 (1): 37.
27. Ichise M, et al. Assessment of regional cerebral perfusion by 99 Tcm-HMPAO SPECT in chromic fatigue syndrome. Nucl Med Com. 1992; 13 (10): 767-772.
28. Ablashi DV, et al. Antiviral activity in vitro of Kutapressin against HHV-6. CID 1994; 18 (suppl 1) S: 113.
29. Ablashi DV, et al. Use of anti-HHV-6 transfer factors for the treatment of patients with chronic fatigue syndrome: 2 case reports. Biotherapy; 1996; 9: 81-86.
30. Ablashi DV, et al. Chronic fatigue syndrome (CFS): HHV-6 infection, antiviral therapy, analysis of RNAse L proteins, and clinical manifestations. Clinical Virology Conference; May 2000; Clearwater Beach, Florida.
31. Blackbourn DJ, Ambroziak J, Lennette E, Adams M, Ramachandran B, Levy JA. Infectious human herpesvirus-8 in a healthy North American blood donor. Lancet 1997 Mar 1; 349 (9052): 609-611.
32. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type-8 in the general population and in Kaposi's sarcoma patients. Lancet 1996 Sep 28; 348 (9031): 858-861.
33. Ablashi DV, et al. Frequent HHV-6 reactivation in multipe sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000; 16: 129.
34. Secchiero et al. Quantitative PCR for human herpes virus-7. J Clin Microbiol 1997; 33: 21-24.
35. Chatlynne LG, et al. Detection and titration of HHV-8 specific antibodies in sera from AIDS patients and Kaposi's Sarcoma patients using a whole virus ELISA. Blood 1998; 92: 53-58.
36. Buchwald D, Komaroff AL. Review of laboratory findings in patients with chronic fatigue syndrome. Rev Infect Dis; 13: S12-S18.
37. Wagner M, et al. Chronic fatigue syndrome (CFS): A critical evaluation of testing for active human herpes virus-6 (HHV-6) infection: Review of data of 107 cases. J of CFS; 1996; 2 (4): 3-16.
38. Schirmer EC, et al. Differentiation between two distinct classes of viruses now classified as human herpesvirus-6. Proc Natl Acad Sci USA 1991; 88: 5922-5926.
39. Ablashi DV, Eastman HB, Owen CB, Roman MM, Levine SM, Steininger K, Peterson DL, et al. Detection of HHV-6 Infection from the Cerebral Spinal Fluid and Plasma of Chronic Fatigue Syndrome Patients. 5/10-5/12/01, abstract T38.
40. Ablashi DV, et al. Increased activation of human herpesvirus-6 (HHV-6), but not human herpesvirus-7 (HHV-7) or human herpesvirus-8 (HHV-8), in chronic fatigue syndrome (CFS) patients. Presented at the Bi-Annual Research Conference of the AACFS October 10-11, 1998, Cambridge, MA.
41. Knoxx KK, et al. Persistent active human herpesvirus-6 (HHV-6) infections in patients with chronic fatigue syndrome. Presented at the Bi-Annual Research Conference of the AACFS October 10-11, 1998, Cambridge, MA.
42. Wallace HL, Natelson B, et al. Human herpesviruses in chronic fatigue syndrome. Clin Diagnostic Lab Immunol, March 1999; 6 (2): 216-223.
43. Reeves W, Stanley F, et al. Human herpesvirus 6 and 7 in chronic fatigue syndrome: A case control study. Clin Infec Dis 2000; 31: 48-52.
44. Ablashi DV, et al. Antiviral activity in vitro of Kutapressin against human herpesvirus-6. In Vivo; 1994 Jul; 8(4): 581-586.
45. Ablashi DV, et al. HHV-6 infection in HIV infected asymptomatic and AIDS patients. Intervirology 1998a; 41: 1-9.
46. Kostainont U, et al. Primary infection of human herpesvirus-6 in children with vertical infectin of immunodeficiency virus type 1. J Inf Dis 1999; 180: 50-55.